Funding for this research was provided by:
Japan Society for the Promotion of Science (16K19789, 15653129, 15K09977, 16K19790)
Japan Agency for Medical Research and Development (16768966)
Core Research for Evolutional Science and Technology (JPMJCR1652)
Received: 26 May 2017
Accepted: 8 August 2017
First Online: 16 August 2017
Ethics approval and consent to participate
: This study was approved by the Radiation Drug Safety Committee and the Institutional Review Board of National Institute of Radiological Sciences of Japan (#15-010). All procedures performed in the preset study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the ethical standards laid down in the principles of the 1964 Declaration of Helsinki and its later amendment or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: TS has received grant support from Eisai Co., Ltd. All other authors declare that they have no conflict of interest. The precursor and reference standard of [<sup>11</sup>C]HMS011 for the present study were provided by Eisai Co., Ltd.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.